Research Articles | Page 19 | Aplastic Anemia & MDS International Foundation Return to top.
  1. Articles
  2. Research Articles

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria Jan 2021 Leukemia paroxysmal nocturnal hemoglobinuria (PNH)
Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA As compared with BM Aug 2017 Leukemia aplastic anemia
Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS Jun 2020 Leukemia acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial Sep 2014 Leukemia myelodysplastic syndromes (MDS)
Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL) Jun 2020 Leukemia myelodysplastic syndromes (MDS)
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients Jul 2020 Leukemia myelodysplastic syndromes (MDS)
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents Dec 2015 Leuk Res. myelodysplastic syndromes (MDS)
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia Apr 2017 Leuk Res Rep
Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia Jun 2014 Leuk Res Rep aplastic anemia
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes Jul 2014 Leuk Res Rep myelodysplastic syndromes (MDS)
Share with addtoany.com.